7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Amentia in 1 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
Excerpt | Relevance | Reference |
---|---|---|
"Distinguishing Alzheimer's disease from DLB is clinically relevant in terms of prognosis and appropriate treatment." | 1.30 | Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. ( Ballard, C; Burn, D; Court, JA; Jaros, E; Johnson, M; Lloyd, S; Marshall, EF; McKeith, IG; Perry, EK; Perry, RH; Piggott, MA; Thomas, N, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Piggott, MA | 1 |
Marshall, EF | 1 |
Thomas, N | 1 |
Lloyd, S | 1 |
Court, JA | 1 |
Jaros, E | 1 |
Burn, D | 1 |
Johnson, M | 1 |
Perry, RH | 1 |
McKeith, IG | 1 |
Ballard, C | 1 |
Perry, EK | 1 |
1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Amentia
Article | Year |
---|---|
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Autoradiography; Corpus Striatum; Dementia; Dopamine; Fe | 1999 |